Literature DB >> 24162852

Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36.

Dante Neculai1, Michael Schwake, Mani Ravichandran, Friederike Zunke, Richard F Collins, Judith Peters, Mirela Neculai, Jonathan Plumb, Peter Loppnau, Juan Carlos Pizarro, Alma Seitova, William S Trimble, Paul Saftig, Sergio Grinstein, Sirano Dhe-Paganon.   

Abstract

Members of the CD36 superfamily of scavenger receptor proteins are important regulators of lipid metabolism and innate immunity. They recognize normal and modified lipoproteins, as well as pathogen-associated molecular patterns. The family consists of three members: SR-BI (which delivers cholesterol to the liver and steroidogenic organs and is a co-receptor for hepatitis C virus), LIMP-2/LGP85 (which mediates lysosomal delivery of β-glucocerebrosidase and serves as a receptor for enterovirus 71 and coxsackieviruses) and CD36 (a fatty-acid transporter and receptor for phagocytosis of effete cells and Plasmodium-infected erythrocytes). Notably, CD36 is also a receptor for modified lipoproteins and β-amyloid, and has been implicated in the pathogenesis of atherosclerosis and of Alzheimer's disease. Despite their prominent roles in health and disease, understanding the function and abnormalities of the CD36 family members has been hampered by the paucity of information about their structure. Here we determine the crystal structure of LIMP-2 and infer, by homology modelling, the structure of SR-BI and CD36. LIMP-2 shows a helical bundle where β-glucocerebrosidase binds, and where ligands are most likely to bind to SR-BI and CD36. Remarkably, the crystal structure also shows the existence of a large cavity that traverses the entire length of the molecule. Mutagenesis of SR-BI indicates that the cavity serves as a tunnel through which cholesterol(esters) are delivered from the bound lipoprotein to the outer leaflet of the plasma membrane. We provide evidence supporting a model whereby lipidic constituents of the ligands attached to the receptor surface are handed off to the membrane through the tunnel, accounting for the selective lipid transfer characteristic of SR-BI and CD36.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24162852     DOI: 10.1038/nature12684

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

1.  A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand β-glucocerebrosidase.

Authors:  Christina Zachos; Judith Blanz; Paul Saftig; Michael Schwake
Journal:  Traffic       Date:  2012-05-15       Impact factor: 6.215

Review 2.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

3.  Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI.

Authors:  Thomas J F Nieland; Marsha Penman; Limor Dori; Monty Krieger; Tomas Kirchhausen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

4.  Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36.

Authors:  S W Ryeom; R L Silverstein; A Scotto; J R Sparrow
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

5.  Assignment of disulfide bridges in bovine CD36.

Authors:  J T Rasmussen; L Berglund; M S Rasmussen; T E Petersen
Journal:  Eur J Biochem       Date:  1998-10-15

6.  Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase.

Authors:  Judith Blanz; Johann Groth; Christina Zachos; Christina Wehling; Paul Saftig; Michael Schwake
Journal:  Hum Mol Genet       Date:  2009-11-20       Impact factor: 6.150

7.  Contributions of a disulfide bond and a reduced cysteine side chain to the intrinsic activity of the high-density lipoprotein receptor SR-BI.

Authors:  Miao Yu; Thomas Y Lau; Steven A Carr; Monty Krieger
Journal:  Biochemistry       Date:  2012-12-10       Impact factor: 3.162

8.  The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain.

Authors:  X Gu; B Trigatti; S Xu; S Acton; J Babitt; M Krieger
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

9.  Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36.

Authors:  Niladri S Kar; Mohammad Z Ashraf; Manojkumar Valiyaveettil; Eugene A Podrez
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

10.  Novel ENU-induced point mutation in scavenger receptor class B, member 1, results in liver specific loss of SCARB1 protein.

Authors:  Ioannis M Stylianou; Karen L Svenson; Sara K VanOrman; Yanina Langle; John S Millar; Beverly Paigen; Daniel J Rader
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

View more
  106 in total

Review 1.  The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review.

Authors:  Maximiliano Javier Jiménez-Dalmaroni; M Eric Gerswhin; Iannis E Adamopoulos
Journal:  Autoimmun Rev       Date:  2015-08-20       Impact factor: 9.754

2.  Micellar lipid composition affects micelle interaction with class B scavenger receptor extracellular loops.

Authors:  Aurélie Goncalves; Brigitte Gontero; Marion Nowicki; Marielle Margier; Gabriel Masset; Marie-Josèphe Amiot; Emmanuelle Reboul
Journal:  J Lipid Res       Date:  2015-04-01       Impact factor: 5.922

Review 3.  Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.

Authors:  Ashley Gonzalez; Mark Valeiras; Ellen Sidransky; Nahid Tayebi
Journal:  Mol Genet Metab       Date:  2013-12-11       Impact factor: 4.797

Review 4.  Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism.

Authors:  Marta Yanina Pepino; Ondrej Kuda; Dmitri Samovski; Nada A Abumrad
Journal:  Annu Rev Nutr       Date:  2014-05-16       Impact factor: 11.848

Review 5.  Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.

Authors:  Wen-Jun Shen; Jie Hu; Zhigang Hu; Fredric B Kraemer; Salman Azhar
Journal:  Metabolism       Date:  2014-03-21       Impact factor: 8.694

Review 6.  Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization.

Authors:  Jan F C Glatz; Joost J F P Luiken
Journal:  J Lipid Res       Date:  2018-04-07       Impact factor: 5.922

7.  Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.

Authors:  Deborah Doens; Pedro A Valiente; Adelphe M Mfuh; Anh X T Vo; Adilia Tristan; Lizmar Carreño; Mario Quijada; Vu T Nguyen; George Perry; Oleg V Larionov; Ricardo Lleonart; Patricia L Fernández
Journal:  ACS Chem Neurosci       Date:  2017-02-15       Impact factor: 4.418

Review 8.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

9.  CD36 mediates albumin transcytosis by dermal but not lung microvascular endothelial cells: role in fatty acid delivery.

Authors:  Hira Raheel; Siavash Ghaffari; Negar Khosraviani; Victoria Mintsopoulos; Derek Auyeung; Changsen Wang; Yun Hye Kim; Brendan Mullen; Hoon-Ki Sung; May Ho; Gregory Fairn; Dante Neculai; Maria Febbraio; Bryan Heit; Warren L Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-31       Impact factor: 5.464

10.  Tryptophan 415 Is Critical for the Cholesterol Transport Functions of Scavenger Receptor BI.

Authors:  Rebecca L Holme; James J Miller; Kay Nicholson; Daisy Sahoo
Journal:  Biochemistry       Date:  2015-12-23       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.